Mihail Obrocea
2022
In 2022, Mihail Obrocea earned a total compensation of $851.5K as Chief Medical Officer at MAIA Biotechnology, a 60% decrease compared to previous year.
Compensation breakdown
| Bonus | $167,200 |
|---|---|
| Option Awards | $246,110 |
| Salary | $391,083 |
| Other | $47,101 |
| Total | $851,494 |
Obrocea received $391.1K in salary, accounting for 46% of the total pay in 2022.
Obrocea also received $167.2K in bonus, $246.1K in option awards and $47.1K in other compensation.
Rankings
In 2022, Mihail Obrocea's compensation ranked 3,364th out of 5,753 executives tracked by ExecPay. In other words, Obrocea earned more than 41.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,364 out of 5,753 | 42nd |
Division Manufacturing | 1,902 out of 3,133 | 39th |
Major group Chemicals And Allied Products | 906 out of 1,419 | 36th |
Industry group Drugs | 848 out of 1,320 | 36th |
Industry Pharmaceutical Preparations | 617 out of 966 | 36th |
Source: SEC filing on April 19, 2023.
Obrocea's colleagues
We found three more compensation records of executives who worked with Mihail Obrocea at MAIA Biotechnology in 2022.